Latest news
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:13:42 GMTThree New Hires Receive Stock Awards With Up to 4-Year Vesting - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:00 GMTFMR LLC and Abigail Johnson report 10.3M-share Pharma Company NV (NAMS) stake - Stock TitanStock Titan · Thu, 06 Aug 2026 14:34:54 GMTNewAmsterdam Pharma Company N.V. (NAMS) Analyst/Investor Day - Slideshow (NASDAQ:NAMS) 2026-08-05 - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 18:10:04 GMTNewAmsterdam Pharma Company N.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 15:53:29 GMTNewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 13:55:03 GMTNewAmsterdam Pharma Company N.V. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 12:46:24 GMTNewAmsterdam Pharma Co N.V. Q2 2026: Revenue $3.7M, EPS $(0.52) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 11:11:01 GMT